IHE - Ola Ghatnekar

IHE News Publications IHE Information Conference

The Swedish Institute
for Health Economics
Box 2127
S-220 02 Lund
Visiting address:
Råbygatan 2
Phone: +46 46 - 32 91 00
info@ihe.se

Ola Ghatnekar

M.Sc. | Research Manager

Work areas

Health economic evaluations of pharmaceuticals and medical devices by means of modelling- and/or literature studies
Cost of illness/treatment studies by means of patient data- and/or literature studies
Pricing and reimbursement
Training in health economics

Therapeutical areas:
Stroke and cardiovascular diseases, cancer and haematological diseases

Selected publications

Ghatnekar O, Hjortsberg C, Gisslén M, Lindbäck S & Löthgren M
Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden
Pharmacoeconomics, 2010; 28 Suppl 1: 49-57

Ghatnekar O, Hjalte F &Taylor M
Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib - a Swedish model application
Acta Oncol. 2010 Aug; 49(6): 851-8

Arana A, Allen S, Burkowitz J, Fantoni V, Ghatnekar O, Rico M T, Vanhaverbeke N, Wentworth C E, Brosa M & Arellano F M
Infliximab Paediatric Crohn’s Disease Educational Plan. A European, Cross-Sectional, Multicentre Evaluation
Drug Safety Journal 2010; 33(6): 489-501

Ghatnekar O & Glader, E-L
The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001
Value in Health, 2008; 11(5):862-868

Ghatnekar O, Alvegård T, Conradi N, Lenhoff S, Mellqvist UH, Persson U &Löthgren M
Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis
Clinical Therapeutics. 2008;30(9):1704-1713

Ghatnekar O, Persson, U, Glader E-L, Terént A. Cost of stroke in Sweden: an incidence estimate. International Journal of Technology Assessment in Health Care, 2004. 20(3): 375-380.

Persson U, Ghatnekar O. Cost-effectiveness analysis of inhaled corticosteroids in asthma: a review of the analytical standards. Respiratory Medicine, 2003; 97(1): 1-1.